FY2019 Earnings Estimate for Allscripts Healthcare Solutions Inc Issued By Piper Jaffray Companies (NASDAQ:MDRX)

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) – Equities research analysts at Piper Jaffray Companies lifted their FY2019 earnings per share estimates for shares of Allscripts Healthcare Solutions in a report issued on Tuesday, November 5th. Piper Jaffray Companies analyst S. Wieland now forecasts that the software maker will post earnings of $0.49 per share for the year, up from their previous estimate of $0.48. Piper Jaffray Companies also issued estimates for Allscripts Healthcare Solutions’ Q4 2019 earnings at $0.13 EPS, Q1 2020 earnings at $0.12 EPS, Q2 2020 earnings at $0.14 EPS, Q3 2020 earnings at $0.14 EPS, Q4 2020 earnings at $0.18 EPS, FY2020 earnings at $0.56 EPS, Q1 2021 earnings at $0.15 EPS, Q2 2021 earnings at $0.16 EPS, Q3 2021 earnings at $0.16 EPS and FY2021 earnings at $0.70 EPS.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Monday, November 4th. The software maker reported $0.17 EPS for the quarter, meeting analysts’ consensus estimates of $0.17. The company had revenue of $445.00 million during the quarter, compared to analysts’ expectations of $450.04 million. Allscripts Healthcare Solutions had a return on equity of 5.98% and a net margin of 12.00%. Allscripts Healthcare Solutions’s revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.18 EPS.

A number of other analysts have also recently commented on MDRX. TheStreet raised Allscripts Healthcare Solutions from a “d+” rating to a “c-” rating in a research note on Friday, September 20th. Cantor Fitzgerald reiterated a “neutral” rating on shares of Allscripts Healthcare Solutions in a research report on Tuesday. Jefferies Financial Group initiated coverage on Allscripts Healthcare Solutions in a research report on Friday, August 23rd. They issued a “buy” rating and a $13.00 price objective for the company. Evercore ISI reiterated a “hold” rating and issued a $11.50 price objective on shares of Allscripts Healthcare Solutions in a research report on Sunday, August 11th. Finally, Robert W. Baird set a $13.00 price objective on Allscripts Healthcare Solutions and gave the company a “buy” rating in a research report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. Allscripts Healthcare Solutions currently has a consensus rating of “Hold” and an average price target of $11.75.

Shares of MDRX stock traded down $0.06 on Friday, reaching $11.21. The company had a trading volume of 13,028 shares, compared to its average volume of 1,551,409. The company has a current ratio of 0.66, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The stock has a market cap of $1.89 billion, a PE ratio of 20.36, a PEG ratio of 2.62 and a beta of 1.39. The company has a 50-day moving average of $10.83 and a 200-day moving average of $10.39. Allscripts Healthcare Solutions has a 12 month low of $8.54 and a 12 month high of $12.40.

Institutional investors and hedge funds have recently modified their holdings of the stock. Northern Trust Corp grew its position in shares of Allscripts Healthcare Solutions by 9.7% in the 2nd quarter. Northern Trust Corp now owns 2,906,636 shares of the software maker’s stock valued at $33,804,000 after purchasing an additional 256,892 shares during the period. Tyers Asset Management LLC grew its position in shares of Allscripts Healthcare Solutions by 7.7% in the 2nd quarter. Tyers Asset Management LLC now owns 24,068 shares of the software maker’s stock valued at $280,000 after purchasing an additional 1,716 shares during the period. Candriam Luxembourg S.C.A. boosted its position in Allscripts Healthcare Solutions by 114.3% during the 2nd quarter. Candriam Luxembourg S.C.A. now owns 75,000 shares of the software maker’s stock worth $868,000 after acquiring an additional 40,000 shares during the last quarter. Rothschild & Co. Asset Management US Inc. boosted its position in Allscripts Healthcare Solutions by 6.1% during the 2nd quarter. Rothschild & Co. Asset Management US Inc. now owns 1,139,996 shares of the software maker’s stock worth $13,258,000 after acquiring an additional 65,924 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in Allscripts Healthcare Solutions by 77.6% during the 2nd quarter. AQR Capital Management LLC now owns 363,152 shares of the software maker’s stock worth $4,198,000 after acquiring an additional 158,722 shares during the last quarter.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.

Recommended Story: CBOE Russell 2000® Volatility Index

Earnings History and Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply